Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders		 Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Overview | Agenda | Hotel Accommodations | Registration

Symposium Chair

Steven T. Rosen, MD, FACP
Steven T. Rosen, MD, FACP
Director, Robert H. Lurie Cancer Center
Northwestern University
Chicago, IL

Expert Faculty

Michael Deininger, MD, PhD
Michael Deininger, MD, PhD
Chief, Division of Hematology and Hematologic Malignancies
M.M. Wintrobe Professor of Medicine
University of Utah
Huntsman Cancer Institute
Salt Lake City, UT

Leo I. Gordon, MD
Leo I. Gordon, MD
Professor, Division of Hematology / Oncology
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL

Andre Goy, MD, MS
André Goy, MD, MS
Chief, Lymphoma Division
The Cancer Center
Hackensack University Medical Center
Hackensack, NJ

Virginia M. Klimek, MD
Virginia M. Klimek, MD
Associate Professor of Medicine
Leukemia Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, NY

Tibor Kovacsovics, MD
Tibor Kovacsovics, MD
Associate Professor of Medicine
Director, Acute Leukemia Program
Center for Hematologic Malignancies
Oregon Health & Science University
Portland, OR

John P. Leonard, MD
John P. Leonard, MD
Professor of Medicine
Weill Cornell Medical College
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medical College
New York, NY

Shuo Ma, MD, PhD
Shuo Ma, MD, PhD
Assistant Professor of Medicine
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL

Nikhil C. Munshi, MD
Nikhil C. Munshi, MD
Associate Professor of Medicine
Harvard Medical School
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

Owen A. OConnor, MD
Owen A. O'Connor, MD
Chief, Division of Hematology and Medical Oncology
Deputy Cancer Center Director
NYU Cancer Institute
NYU Langone Medical Center
New York, NY

S. Vincent Rajkumar, MD
S. Vincent Rajkumar, MD
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN

Tait D. Shanafelt, MD
Tait D. Shanafelt, MD
Associate Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN

Sonali Smith, MD
Sonali Smith, MD
Associate Professor of Medicine
Division of Hematology
Department of Medicine
University of Chicago Medical Center
Chicago, IL

Martin S. Tallman, MD
Martin S. Tallman, MD
Chief of Leukemia Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY

Moshe Talpaz, MD
Moshe Talpaz, MD
Professor, Department of Internal Medicine
Alexander J. Trotman Professor of Leukemia Research
Associate Director of Translational Research
Associate Chief/Director of Hematologic Malignancies
University of Michigan Comprehensive Cancer Center
Ann Arbor, MI

Thomas E. Witzig, MD
Thomas E. Witzig, MD
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
College of Medicine
Rochester, MN

Anas Younes, MD
Anas Younes, MD
Director, Clinical and Translational Research Program
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas M.D. Anderson Cancer Center
Houston, TX

2nd Annual Symposium on
Personalized Therapies and Best Clinical Practices
for
Hematologic Malignancies

Grand Hyatt Tampa Bay ~ Saturday February 5, 2011

CASE-BASED LEARNING

Click here for the agenda

This past year a tremendous amount of new "practice-changing" data affecting how you treat, manage and care for your hematology patients has been published. For your lymphoma, myeloma and leukemia patients this symposium will help you apply the new first-line and maintenance therapy data as well as the best practices for your refractory and relapsed patients.

Taught by the expert hematology academics who are highly effective and engaging teachers, this Patient Case-Based program is the ONE symposium on hematologic malignancies that you should attend in 2011. It also provides the important highlights and data from the December 2010 ASH Symposium. So if there is only one hematology CME symposium that you should attend in 2011, please join us on February 5, 2011 in Tampa, FL. This is the second year of this very special symposium. It promises to continue to attract a full room of hematologists and allied health care professionals like you who will leave the symposium with the expert knowledge and competence needed to improve outcomes for patients with hematologic malignancies.

Register now for a guaranteed symposium seat, discounted tuition, hotel room rates and airline fares. Like last year, attendance will reach its maximum. Don't miss this opportunity.

   
•
 Overview
•
 Educational Statement of Need
•
 Disclosure
•
 Target Audience
•
 Learning Objectives
•
 CME Credit Information
•
 Agenda
•
 Grand Hyatt Tampa Bay
•
 Registration
•
 Exhibit
•
 Southwest Airlines
   
Expert Faculty Back to Top


Jessica K. Altman, MD
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL



 


S. Vincent Rajkumar, MD
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN




Bruce D. Cheson, MD
Professor of Medicine
Hematology/Oncology
Head of Hematology
Director, Hematology Research
Lombardi Comprehensive Cancer Center
Georgetown University Hospital
Washington, DC



 


Steven T. Rosen, MD, FACP
Director, Robert H. Lurie Cancer Center
Northwestern University
Chicago, IL




Michael Deininger, MD, PhD
Professor of Medicine
Division of Hematology & Medical Oncology
Section Head, Center for Hematologic Malignancies
Oregon Health & Science University
Portland, OR



 


Tait D. Shanafelt, MD
Associate Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN




Madeleine Duvic, MD
Deputy Department Chair
Department of Dermatology
Professor of Medicine and Dermatology
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

 


Moshe Talpaz, MD
Professor, Department of Internal Medicine
Alexander J. Trotman Professor of Leukemia Research
Associate Director of Translational Research
Associate Chief/Director of Hematologic Malignancies
University of Michigan Comprehensive Cancer Center
Ann Arbor, MI




Andrew Evens, MD
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL



 


Julie M. Vose, MD
Neumann M. and Mildred E. Harris Professor
Chief, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE




Steven D. Gore, MD
Professor of Hematology/Oncology
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, MD



 


Thomas E. Witzig, MD
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
College of Medicine
Rochester, MN




André Goy, MD, MS
Chief, Lymphoma Division
The Cancer Center Hackensack University Medical Center
Hackensack, NJ



 


Anas Younes, MD
Director, Clinical and Translational Research Program
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas M.D. Anderson Cancer Center
Houston, TX




Richard A. Larson, MD
Professor of Medicine
Director of Hematologic Malignancies Clinical Research Program
The University of Chicago Medical Center
Chicago, IL

 


Andrew D. Zelenetz, MD, PhD
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, NY




Nikhil C. Munshi, MD
Associate Professor of Medicine
Harvard Medical School
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

 


Jane N. Winter, MD
Professor of Medicine
Division of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL



Educational Grants

Sincere appreciation is extended to the following companies for their generous commercial support of this educational meeting:
© 2012 Biomedical Learning Institute
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.